Vascular damage in systemic lupus erythematosus

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Nature Reviews Nephrology

• Publication date

  2024-01-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41581-023-00797-8PMID 38172627PMCID PMC11391830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis.

  2023cited by this paper
• Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

  2022cited by this paper
• Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study.

  2022cited by this paper
• Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

  2022cited by this paper
• Oral surveillance and JAK inhibitor safety: the theory of relativity

  2022cited by this paper
• Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus

  2022cited by this paper
• Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus

  2022cited by this paper
• Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.

  2022cited by this paper
• EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

  2022cited by this paper
• Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations.

  2022cited by this paper
• OUP accepted manuscript

  2022cited by this paper
• Clonal hematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).

  2022cited by this paper
• Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: NHANES 2011–2018

  2022cited by this paper
• Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.

  2022cited by this paper
• GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes.

  2022cited by this paper
• The evolving story of apolipoprotein L1 nephropathy: the end of the beginning

  2022cited by this paper
• Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome

  2022cited by this paper
• Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus

  2022cited by this paper
• Low‐density granulocytes in systemic autoimmunity and autoinflammation

  2022cited by this paper
• Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation

  2022cited by this paper
• OUP accepted manuscript

  2022cited by this paper
• Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases

  2022cited by this paper
• Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus

  2022cited by this paper
• Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.

  2022cited by this paper
• Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation

  2021cited by this paper
• RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells

  2021cited by this paper
• Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus

  2021cited by this paper
• Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

  2021influential reference
• Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition.

  2021cited by this paper
• Health inequities and the inappropriate use of race in nephrology

  2021cited by this paper
• IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice

  2021cited by this paper
• Once-Weekly Semaglutide in Adults with Overweight or Obesity.

  2021cited by this paper
• Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus

  2021cited by this paper
• All-cause and Cause-specific Mortality in Systemic Lupus Erythematosus: A Population-based Study.

  2021cited by this paper
• Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

  2021cited by this paper
• Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study

  2021cited by this paper
• Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries.

  2021cited by this paper
• Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study

  2021cited by this paper
• A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus

  2021cited by this paper
• Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidney

  2021cited by this paper
• Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus

  2021cited by this paper
• Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

  2021cited by this paper
• Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies

  2021cited by this paper
• Increased Incidence of Resistant Hypertension in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study

  2020cited by this paper
• Letter by Siontis and Räber Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)".

  2020influential reference
• Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus

  2020cited by this paper
• Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus

  2020cited by this paper
• Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients

  2020cited by this paper
• Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics

  2020cited by this paper
• Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

  2020cited by this paper
• Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials

  2020cited by this paper
• Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.

  2020cited by this paper
• High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index

  2020cited by this paper
• Mapping Systemic Lupus Erythematosus heterogeneity at the single-cell level

  2020cited by this paper
• Skin microvascular dysfunction in systemic lupus erythematosus patients with and without cardiovascular risk factors.

  2020cited by this paper
• T cells expressing the lupus susceptibility allele Pbx1d enhance autoimmunity and atherosclerosis in dyslipidemic mice.

  2020cited by this paper
• Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.

  2020cited by this paper
• Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial.

  2020cited by this paper
• High Burden of Premature Arteriosclerosis on Renal Biopsy Results in Incident Lupus Nephritis

  2020cited by this paper
• Associations of metabolic syndrome in SLE

  2020cited by this paper
• APOL1 variant-expressing endothelial cells exhibit autophagic dysfunction and mitochondrial stress

  2020cited by this paper
• Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction

  2020cited by this paper
• Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

  2020cited by this paper
• Proteomic, biomechanical and functional analyses define neutrophil heterogeneity in systemic lupus erythematosus

  2020cited by this paper
• Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

  2020cited by this paper
• Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity.

  2019cited by this paper
• 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.

  2019cited by this paper
• Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus

  2019influential reference
• Physical activity, sedentary behaviour and their associations with cardiovascular risk in systemic lupus erythematosus.

  2019cited by this paper
• APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore.

  2019cited by this paper
• Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus

  2019cited by this paper
• Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease

  2019cited by this paper
• Trial of Anifrolumab in Active Systemic Lupus Erythematosus.

  2019cited by this paper
• Single-cell immune landscape of human atherosclerotic plaques

  2019cited by this paper
• Systemic lupus erythematosus and hypertension.

  2019cited by this paper
• Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus

  2019cited by this paper
• Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.

  2019influential reference
• The immune cell landscape in kidneys of patients with lupus nephritis

  2019cited by this paper
• 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

  2019cited by this paper
• 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cited by this paper
• Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression.

  2019cited by this paper
• Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE

  2019influential reference
• Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.

  2019cited by this paper
• Nocturnal blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus

  2019cited by this paper
• Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.

  2019cited by this paper
• Reassessing the Mechanisms of Acute Coronary Syndromes: The “Vulnerable Plaque” and Superficial Erosion

  2019cited by this paper
• Development of a systemic lupus erythematosus cardiovascular risk equation

  2019cited by this paper
• Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort

  2018cited by this paper
• Brief Report: Lupus—An Unrecognized Leading Cause of Death in Young Females: A Population‐Based Study Using Nationwide Death Certificates, 2000–2015

  2018cited by this paper
• Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

  2018influential reference
• Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis

  2018cited by this paper
• Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies

  2018cited by this paper
• The immunology of hypertension

  2018cited by this paper
• Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis

  2018cited by this paper
• Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

  2017cited by this paper
• IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus

  2017cited by this paper
• Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1&bgr; Pathway in Systemic Lupus Erythematosus

  2017cited by this paper
• The immunology of atherosclerosis

  2017cited by this paper
• Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta‐analysis

  2017cited by this paper
• Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses’ Health Study cohorts

  2017cited by this paper

• Life towards death: Neutrophils in immune-mediated inflammatory diseases.

  2026cites this paper
• Immunopathogenesis of accelerated atherosclerosis in systemic lupus erythematosus: from innate and adaptive dysregulation to clinical implications

  2026cites this paper
• The shared genetic architecture underlying the autoimmune and cardiovascular disease: a multivariate genome-wide analysis

  2026cites this paper
• Statin therapy in systemic lupus erythematosus: a meta-analysis of disease activity and inflammatory biomarkers

  2026cites this paper
• Purulent Pericarditis With Cardiac Tamponade Triggered by Left-Sided Infective Endocarditis in Active Systemic Lupus Erythematosus: A Case Report.

  2026cites this paper
• The Relationship between PCSK9 and the Occurrence of Atherosclerosis in Patients with Systemic Lupus Erythematosus

  2026cites this paper
• Dermatomyositis is characterized by JAK1-mediated monocyte-driven vasculopathy and inflammation.

  2025cites this paper
• Role of Neutrophils in Homeostasis and Diseases

  2025cites this paper
• Association between age-related cardiovascular disease and systemic lupus erythematosus: a Mendelian randomization analysis

  2025cites this paper
• Conjunctival and retinal microvascular loss in systemic lupus erythematosus: a swept-source OCTA study

  2025cites this paper
• Neutrophil-to-lymphocyte ratio and CD40 as diagnostic biomarkers for systemic lupus erythematosus and its disease activity.

  2025cites this paper
• Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases

  2025cites this paper
• Reply

  2025cites this paper
• Deep learning-driven TCR\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\beta$$\end{document} repertoire analysis enha

  2025cites this paper
• Harnessing biomaterials for tuning inflammation: A neutrophil-centric perspective

  2025cites this paper
• Cardiovascular and neurovascular complications in systemic lupus Erythematosus: A cross-sectional study of subclinical atherosclerosis and cognitive dysfunction

  2025cites this paper
• Self-Adaptive Wound Dressings for Wound Healing and Repair.

  2025cites this paper
• ISCHEMIC STROKE IN YOUNG ADULTS: A MODERN OVERVIEW

  2025cites this paper
• Macrophages Unmasked: Their Pivotal Role in Driving Atherosclerosis in Systemic Lupus Erythematosus

  2025cites this paper
• Engineered MSCs Break Endothelial‐Myofibroblast Crosstalk in Pulmonary Fibrosis: Reconstructing the Vascular Niche

  2025cites this paper
• The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases

  2025cites this paper
• Intracranial vessel wall enhancement scoring system for monitoring disease activity and neuropsychiatric impairment in systemic lupus erythematosus.

  2025cites this paper
• Aberrant expansion of CD177+ neutrophils promotes endothelial dysfunction in systemic lupus erythematosus via neutrophil extracellular traps.

  2025cites this paper
• Long-term exposure to ambient NO2 increase oral cancer prevalence in Southern China: a 3-year time-series analysis

  2025cites this paper
• Lupus nephritis as an independent risk factor for carotid atherosclerosis in patients with systemic lupus erythematosus

  2025cites this paper
• Type I Interferons and Systemic Lupus Erythematosus

  2025cites this paper
• Uteroplacental microvascular remodeling in health and disease

  2025cites this paper
• Bioinformatic analysis and experimental verification reveal expansion of monocyte subsets with an interferon signature in systemic lupus erythematosus patients

  2025cites this paper
• Systemic lupus erythematosus and atherosclerosis: immune pathways and the uncharted territory of gut microbiota and metabolism

  2025influential citation
• Establishment of a lupus-prone mouse model of pulmonary arterial hypertension with intermittent hypoxia: functional, biochemical and histological verifications

  2025cites this paper
• Determining the biomarkers and pathogenesis of myocardial infarction combined with ankylosing spondylitis via a systems biology approach

  2025cites this paper
• Identification of hub immune-related genes and construction of predictive models for systemic lupus erythematosus by bioinformatics combined with machine learning

  2025cites this paper
• Thromboembolic Episodes in Patients with Systemic Lupus Erythematosus Without Atrial Fibrillation/Atrial Flutter Are Related to the Presence of at Least 3 Points in the CHA2DS2-VA Score: A Comprehensive Retrospective Analysis of 787 Patients

  2025cites this paper
• Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion

  2025cites this paper
• Immunometabolism in systemic lupus erythematosus

  2025cites this paper
• NLRP3-Mediated PANoptosis and Associated Interventions in Endothelial Injury

  2025cites this paper
• Risk factors associated with cardiovascular disease in Mexican people with Systemic Lupus Erythematosus

  2025cites this paper
• Immune dysregulation and lipid interactions in systemic lupus erythematosus-associated atherosclerosis: mechanisms and pathogenesis

  2025influential citation
• Developing an Interpretable Machine Learning Model for Early Prediction of Cardiovascular Involvement in Systemic Lupus Erythematosus

  2025cites this paper
• Management of complex symptomatic renal artery aneurysm in a patient with Sjögren’s syndrome and systemic lupus erythematosus

  2025cites this paper
• Type I Interferons in health and disease-Molecular aspects and clinical implications.

  2025cites this paper
• Artesunate Ameliorates SLE Atherosclerosis Through PPARγ-Driven Cholesterol Efflux Restoration and Disruption of Lipid Raft-Organized TLR9/MyD88 Signaling Pathway

  2025cites this paper
• Neutrophil extracellular traps and neuropsychiatric lupus: Signaling pathways involved in NET formation and mechanisms affecting the central nervous system.

  2025cites this paper
• Cross-disease comparison of dermatomyositis and lupus skin identifies inflammatory monocytes and JAK-1 signaling as drivers of vasculopathy in dermatomyositis

  2025cites this paper
• Blood–labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus

  2025cites this paper
• Basophil-derived exosomes exacerbate systemic lupus erythematosus by regulating B-cell proliferation via miR-24550

  2025cites this paper
• Exploring the role of neutrophil extracellular traps in colorectal cancer: Insights from single-cell sequencing

  2025cites this paper
• Serum levels of PECAM-1, ICAM-1, and VCAM-1 in patients with systemic lupus erythematosus: associations with disease activity and clinical features from a single-center study

  2025cites this paper
• Anti‐transcription intermediate factor 1‐γ antibody‐positive dermatomyositis with refractory skin ulcers and rapid cancer progression

  2024cites this paper
• From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases

  2024cites this paper
• Neutrophil diversity and function in health and disease

  2024cites this paper
• Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus

  2024cites this paper
• The Causal Relationship between Immune-Mediated Inflammatory Diseases and Aortic Aneurysm: A Bidirectional Two-Sample Mendelian Randomization Study

  2024cites this paper
• The role of neutrophil extracellular traps in inflammatory rheumatic diseases

  2024cites this paper
• Pathological mechanisms and crosstalk among various cell death pathways in cardiac involvement of systemic lupus erythematosus

  2024cites this paper
• The immunology of systemic lupus erythematosus

  2024influential citation
• Emerging Molecular and Synaptic Targets for the Management of Chronic Pain Caused by Systemic Lupus Erythematosus

  2024cites this paper
• Autoimmune diseases and atherosclerotic cardiovascular disease

  2024cites this paper
• World Journal of Gastrointestinal Oncology

  year unknowncites this paper